Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality?
Authors:
Open Access
Abstract
The prerequisite for salvage of myocardium under threat of infarction is the return of coronary flow to the tissue as quickly as possible.2 , 3 The major clinical approach to reperfusion is the use of thrombolytics. However, fibrinolysis is not instantaneous and while the coronary thrombus is lysing, the subtended myocardium continues to undergo injury, which is ultimately irreversible. The administration of injury modifying manoeuvres could occur either before the onset of ischaemia, or after the onset of ischaemia but before therapeutic reperfusion.Keywords
This publication has 47 references indexed in Scilit:
- Prolonging the Delayed Phase of Myocardial Protection: Repetitive Adenosine A1Receptor Activation Maintains Rabbit Myocardium in a Preconditioned State 11Dr. Dana is supported by a Junior Research Fellowship, and Dr. Baxter by an Intermediate Fellowship, from the British Heart Foundation, London. Continuing support (Drs. Dana and Baxter) is provided by the Hatter Foundation, London.JACC, 1998
- Ischemic Preconditioning and Morphine-induced Cardioprotection Involve the Delta (δ)-opioid Receptor in the Intact Rat HeartJournal of Molecular and Cellular Cardiology, 1997
- Selective adenosine A3 receptor stimulation reduces ischemic myocardial injury in the rabbit heartCardiovascular Research, 1997
- Cardioprotection by ACE Inhibitors in Myocardial Ischaemia/ReperfusionDrugs, 1997
- Infarct size-reducing effect of nicorandil is mediated by the KATP channel but not by its nitrate-like properties in dogsCardiovascular Research, 1996
- Bradykinin as an endogenous myocardial protective substance with particular reference to ischemic preconditioning–a brief review of the evidenceCanadian Journal of Physiology and Pharmacology, 1995
- Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitationTrends in Pharmacological Sciences, 1994
- Thrombolysis in Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)The Lancet, 1992
- Myocardial reperfusion: a double-edged sword?Journal of Clinical Investigation, 1985